ArticleFrontiers in oncology2025

Hyperprogression disease induced by Sintilimab combined with Oxaliplatin and S-1 after surgery: a case report and literature review.

Yaoqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.